Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma

Fig. 2

CD58 level in pancreatitis and pancreatic cancer tissues by bioinformatics analysis. a Logsdon’ data showed that CD58 was upregulated in pancreatitis tissues (n = 5) compared with the normal pancreas tissues (n = 5), p = 0.030. b, c Bedea and Segara’s data displayed that CD58 was increased in PDAC tissues relative to the normal pancreas tissues. d GEPIA online tool confirmed this finding by analyzing TCGA and GTEx databases. N (normal) = 171; N (tumor) = 179; p < 0.01. PAAD pancreatic adenocarcinoma. e After dividing 176 pancreatic cancer patients into a high-risk group and a low-risk group according to the prognosis index, SurvExpress platform showed that the level of CD58 in the high-risk group (n = 88) was higher than that in the low-risk group (n = 88), p < 0.001

Back to article page